Product Information
METRONIDAZOLE TOPICAL 1% GEL is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.6209 per GM under NDC 62332063060. Its NADAC has been published 245 times since Dec 15, 2021.
FDA first approved this application on Sep 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/g
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA212646FDA Approved
9/3/2021
TE Code
AB
On Market Since
9/6/2021
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE TOPICAL 1% GEL has been published 245 times since Dec 15, 2021, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6209 per GM |
|---|---|
| All-time high | $1.7413 (Dec 15, 2021) |
| All-time low | $0.5951 (May 22, 2024) |
| 52-week high | $0.8011 |
| 52-week low | $0.6209 |
| Median price | $0.8411 |
| Average price | $0.8886 |
| Largest weekly change | +38.7% (Jun 19, 2024) |
| Weeks tracked | 245 |
| Tracking since | Dec 15, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE TOPICAL 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 1% GEL, manufactured by Alembic Pharmaceuticals Inc., is $0.6209 per GM (NDC 62332063060), effective Aug 19, 2026.
How has the price of METRONIDAZOLE TOPICAL 1% GEL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has declined 64.3%. It has been tracked across 245 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 1% GEL?
Since Dec 15, 2021, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has ranged from a low of $0.5951 (May 22, 2024) to a high of $1.7413 (Dec 15, 2021), with a median of $0.8411 per GM.
Are there cheaper alternatives to METRONIDAZOLE TOPICAL 1% GEL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE TOP 1% GEL PUMP, is $0.5229 per GM — about 16% below METRONIDAZOLE TOPICAL 1% GEL.
Who manufactures METRONIDAZOLE TOPICAL 1% GEL?
METRONIDAZOLE TOPICAL 1% GEL (NDC 62332063060) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.